ARCHIVES

Phase II Study Meets Primary Endpoint, Demonstrating Overall Survival of 5.2 Months

This article is from The Cancer Letter archive.

Vol. 36 No. 9 | September 27, 2013

Download PDF Visit The Full Archive

Related Articles

Only Seven Of 66 “Benign” Breast Cancer Turn Out to Be Doubtful

November 25, 1977

Two Children Achieve Remission With CD19 Immunotherapy

March 29, 2013

Bush Vetoes HHS Budget Bill, House Votes To Sustain.

November 23, 2007

New Patterns Of Care Study Okayed By DCT Board

June 13, 1986

In Brief: Georgetown Professor Heads Cancer Therapy Evaluation Program; NCI-VA Branch Abolished

September 7, 1979

House, Senate Committee Increase FDA Funding, Drop User Fees

August 4, 1989